PQ 165
165. Deputy Neasa Hourigan asked the Minister for Health when the HSE management team is expected to make a final decision on the reimbursement of Dupilumab for the treatment of atopic eczema; and if he will make a statement on the matter. [37144/20]
Introduced
18 November 2020
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
18 November 2020
Summary
165. Deputy Neasa Hourigan asked the Minister for Health when the HSE management team is expected to make a final decision on the reimbursement of Dupilumab for the treatment of atopic eczema; and if he will make a statement on the matter. [37144/20]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medicinal Products
Medicinal Products
xml · EN · 18 November 2020
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2020-11-18/165/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2020-11-18/pq_165